Clinical Trial Update: Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19 [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, multicenter trial evaluating PLX PAD for treating COVID-19 and ARDS has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• PLX PAD

Snippet

Sponsor: Pluristem Ltd. | Conditions: COVID, ARDS | Phase 2 | Status: TERMINATED